FINNENCE▪
00:00:00 UTCSYS ONLINE
FINNENCE ▪ THE WIRE FILE

THE WIRE · № 68847

News■ Unclear/unknown

InflammaSense Named Performer on ARPA-H's up to $38 Million CIRCLE Award to Advance Real-Time Immune Monitoring in Critical Care

EXHIBIT · mmx.prnewswire.com
KINDNews
DIRECTION■ Unclear/unknown
SOURCES1
ENTITIES1
STORY SIZESTANDALONE
FIRST SEEN2026-10-07 10:00 UTC
LAST UPDATE2026-10-07 10:00 UTC
STATEactive

01 THE MACHINE READ

WHY IT MATTERS.

ARPA-H award to a pre-revenue medtech shows government funding for immune monitoring, but no listed exposure.

Early-stage grant, no investable vehicle named
CATALYST TO WATCH

Trial enrollment and future funding rounds

MAIN RISK

Pre-revenue company may not commercialize

FULL DISPATCH

Company will measure autonomic and inflammatory signatures in up to 200 critically ill patients using its VITALx-patch wearable sensor and ARC cascade-endotyping classifier LA JOLLA, Calif., Oct. 7, 2026 /PRNewswire/ -- InflammaSense, Inc., a pre-revenue medtech company developing...

02 THE STORY SO FAR

THE RECORD, IN ORDER.

STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.

03 WHO'S INVOLVED

ENTITIES ON FILE.

AFFECTEDHealthcare

04 RECEIPTS

THE SOURCE RECORD.

1 SOURCES CONFIRMED
№ 01prnewswireprnewswire.com · PRIMARY2026-10-07 10:00 UTCOPEN RECEIPT →

05 PROPAGATION

WHAT THIS TOUCHES.

KEEP READING THE MACHINE

OPEN THE MACHINE →THE PREDICTION LEDGER →

Summaries are generated and may contain errors — every claim links its sources.